Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a consent form agreeing to take part in the trial
- People aged between 20 and 80 years old
- People whose liver function falls into Category A or B on a standard liver health scoring system called Child-Pugh (confirm with trial site)
- People whose blood test results for liver-related markers (bilirubin, ALT, and AST) are within an acceptable range, as determined by standard laboratory limits
Who may not be able to join:
- People who are unwilling to sign the consent form
- People whose liver function falls into the most severe category (Child-Pugh Class C) on the liver health scoring system
- People who have a blood clot blocking the main blood vessel leading to the liver (main portal vein thrombosis)
- People whose liver tumours are spread widely throughout the entire liver (diffuse liver tumours)
- People who have had an allergic reaction to contrast dye, which is a substance sometimes used during medical imaging procedures
- People whose blood does not clot normally
- People with serious problems affecting the brain, heart, or lungs
- People with severe kidney problems, unless they are already receiving kidney dialysis treatment
- People who are unable to cooperate with the procedures involved in the trial
- People with an irregular heartbeat that is not under control, or unstable blood pressure
- Some people with certain abnormal thyroid function results (confirm with trial site for details)
- People with other conditions that may prevent safe participation, such as active bleeding in the stomach or intestines, fluid build-up in the abdomen that cannot be managed, or severely high blood pressure in the liver's blood vessels
- Women who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +886-0436060666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes of serum Aspartate Transaminase (AST) level after TACE; Changes of serum Alanine Aminotransferase (ALT) level after TACE; Changes of serum total bilirubin level after TACE; Changes of serum albumin level after TACE; Changes of prothrombin time after TACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.